Zobrazeno 1 - 10
of 29
pro vyhledávání: '"O P, Asthana"'
Publikováno v:
Phytotherapy Research. 14:443-447
The present report, describes for the first time the clinical efficacy of curcumin, the active constituent of rhizomes of Curcuma longa, in the treatment of patients suffering from idiopathic inflammatory orbital pseudotumours. Curcumin was administe
Publikováno v:
Phytotherapy Research. 13:318-322
Curcumin, obtained from rhizomes of Curcuma longa, was administered orally to patients suffering from chronic anterior uveitis (CAU) at a dose of 375 mg three times a day for 12 weeks. Of 53 patients enrolled, 32 completed the 12-week study. They wer
Publikováno v:
Indian Journal of Psychiatry
Several studies suggest that a low cholesterol concentration is associated with depression. The authors sought to determine whether an association exists between serum lipid concentrations and depression. 28 drug-naive patients of major depression di
Publikováno v:
Indian Journal of Psychiatry
A double blind study was undertaken to compare the efficacy between centbutindole and haloperidol. A total of 44 patients suffering from schizophrenia diagnosed in accordance to ICD-10 criteria were included. They were randomly assigned into two grou
Autor:
S, Verma, J K, Trivedi, H, Singh, P K, Dalal, O P, Asthana, J S, Srivastava, R, Mishra, Ramakant, P K, Sinha
Publikováno v:
Indian Journal of Psychiatry
Practical difficulties associated with assessment of central parameters necessitates the development of peripheral markers of suicidal risk. Recent research suggest that serum lipid profile may be a useful indicator of suicidal behaviour. Serum lipid
Publikováno v:
Indian Journal of Psychiatry
Centbutindole is a new antipsychotic agent related to butyrophenone group. The drug is dopamine antagonist but it also blocks 5HT2 receptors. Clinically the drug has passed through phase I, II & III clinical trials successfully and it has shown effec
Publikováno v:
The Journal of the Association of Physicians of India. 50
To undertake post-marketing surveillance (PMS) of arteether (E-Mal) with the aim of obtaining feedback from clinicians regarding its safety, tolerability, efficacy and adverse event profile in patients of P. falciparum malaria.Post-marketing surveill
Autor:
O P, Asthana, J S, Srivastava, T K, Pandey, K A, Vishwanathan, V, Dev, K M, Mahapatra, N C, Nayak, A B, Balsara, O P, Mandal, N, Gupta, S K, Mishra, S, Mohanty, S, Sathpathy, B S, Das, J K, Patnaik, S K, Sathpathy, B, Dash
Publikováno v:
The Journal of the Association of Physicians of India. 49
To evaluate efficacy of alpha;beta arteether in patients of P. falciparum malaria presenting with complications was undertaken in a multicentric clinical trial.Each patient who consented to undergo clinical trial with parenteral Arteether was treated
Autor:
O P, Asthana, J S, Srivastava, V P, Kamboj, N, Valecha, V P, Sharma, S, Gupta, T K, Pande, K A, Vishwanathan, K M, Mahapatra, N C, Nayak, P K, Mahapatra, J, Mahanta, V K, Srivastava, Vasdev, N, Singh, M M, Shukla, A B, Balsara, S K, Mishra, S K, Satpathy, S, Mohanty, B, Dash
Publikováno v:
The Journal of the Association of Physicians of India. 49
Two hundred and sixty seven patients of uncomplicated P. falciparum malaria completed study in a multicentric phase III clinical trial of Arteether. Arteether was given intramuscularly in a dose of 150 mg daily for three consecutive days. Each patien
Publikováno v:
Leprosy Review. 72
Single dose vaccination was carried out with Mycobacterium habana vaccine, 31 lepromatous leprosy cases receiving 1.5 mg (1.5 mg = 6.27 x 10(8) bacilli) and 36 household contacts randomly receiving 1.5, 2.0, 2.5 mg vaccine intradermally. Duration of